SOPHiA GENETICS SA (SOPH) Free cash flow 2019–2025
SOPHiA GENETICS SA (SOPH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$36.5MFY2025 · since FY2019: -$33.0M → -$36.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.5M | +18.5% |
| FY2024 | -$44.8M | +18.2% |
| FY2023 | -$54.7M | +26.2% |
| FY2022 | -$74.2M | -22.4% |
| FY2021 | -$60.6M | -88.4% |
| FY2020 | -$32.2M | +2.6% |
| FY2019 | -$33.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SOPH financial trends
SOPH RevenueSOPH Net incomeSOPH Net marginSOPH Gross profitSOPH Gross marginSOPH Operating incomeSOPH Operating marginSOPH Operating cash flowSOPH Capital expendituresSOPH Return on equitySOPH Stock buybacksSOPH Dividends paidSOPH Total assetsSOPH Total liabilitiesSOPH Shareholders’ equitySOPH overview →